New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

Dissolvable film BNT23001 led to about 40% higher cladribine exposure than tablets in a preclinical pig study, BioNxt ...

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

This approval allows Bionpharma to commercialize the product in the United States, expanding patient access to a more ...